Impact of COVID-19 pandemic on adherence to chronic therapies: a systematic review

E Olmastroni, F Galimberti, E Tragni… - International journal of …, 2023 - mdpi.com
The spread of the coronavirus disease 2019 (COVID-19) pandemic caused a sudden and
significant disruption in healthcare services, especially for patients suffering from chronic …

Telemedicine and virtual respiratory care in the era of COVID-19

H Pinnock, P Murphie, I Vogiatzis… - ERJ open …, 2022 - Eur Respiratory Soc
The World Health Organization defines telemedicine as “an interaction between a
healthcare provider and a patient when the two are separated by distance”. The coronavirus …

The impact of the war on maintenance of long-term therapies in Ukraine

N Khanyk, B Hromovyk, O Levytska, T Agh… - Frontiers in …, 2022 - frontiersin.org
Due to the Russian invasion, which started on 24 February 2022, the Ukrainian healthcare
system is facing multiple challenges. A great number of healthcare facilities have been …

Comparison of drug prescribing before and during the COVID‐19 pandemic: a cross‐national European study

I Selke Krulichová, GW Selke, M Bennie… - … and drug safety, 2022 - Wiley Online Library
Purpose The COVID‐19 pandemic had an impact on health care, with disruption to routine
clinical care. Our aim was to describe changes in prescription drugs dispensing in the …

COVID-19 pandemic has disrupted the continuity of care for chronic patients: evidence from a cross-sectional retrospective study in a developing country

A Dehghani Tafti, A Fatehpanah, I Salmani… - BMC Primary …, 2023 - Springer
Background Any disruption in continuity of care for patients with chronic conditions can lead
to poor outcomes for the patients as well as great damage for the community and the health …

A cross-sectional survey on medication management practices for noncommunicable diseases in Europe during the second wave of the COVID-19 pandemic

T Ágh, JFM van Boven, B Wettermark… - Frontiers in …, 2021 - frontiersin.org
Maintaining healthcare for noncommunicable diseases (NCDs) is particularly important
during the COVID-19 pandemic; however, diversion of resources to acute care, and physical …

European network to advance best practices and technology on medication adherence: mission statement

JFM van Boven, I Tsiligianni, I Potočnjak… - Frontiers in …, 2021 - frontiersin.org
Medication non-adherence is associated with almost 200,000 deaths annually and€ 80–125
billion in the European Union. Novel technological advances (smart pill bottles, digital …

Reimbursed medication adherence enhancing interventions in 12 European countries: Current state of the art and future challenges

P Kardas, M Bago, P Barnestein-Fonseca… - Frontiers in …, 2022 - frontiersin.org
Background: Medication non-adherence jeopardises the effectiveness of chronic therapies
and negatively affects financial sustainability of healthcare systems. Available medication …

Impact of the Covid pandemic on timely cancer diagnosis across European healthcare settings: a scoping review

F Pennisi, S Odelli, S Borlini, F Morani… - Annali di Igiene …, 2024 - discovery.ucl.ac.uk
Introduction: The COVID-19 pandemic presented unprecedented challenges to European
healthcare systems. The study aimed to review the available evidence on the impact of the …

Adherence during COVID-19: The role of aging and socio-economics status in shaping drug utilization

C Di Novi, L Leporatti, R Levaggi… - Journal of Economic …, 2022 - Elsevier
Our study investigates the potential impact that COVID-19 and lockdown restrictions may
have had on drug utilization and the role of patient age and education in reshaping it. We …